CNS Pharmaceuticals Competitors and Similar CompaniesClear all
CNS Pharmaceuticals's competitors and similar companies include INmune Bio, Dare Bioscience, Cytodyn and Northwest Biotherapeutics.
 CNS Pharmaceuticals CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors. |  INmune Bio INmune Bio is a clinical-stage biotechnology company that develops immunotherapies that reprogram a patient’s innate immune system. |  Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases. |  Cytodyn CytoDyn is a biotechnology company developing therapies to address cancer, HIV, and other autoimmune diseases. |  Northwest Biotherapeutics Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer. | |
Founding Date | Founding Date 2017 | Founding Date 2015 | Founding Date 2006 | Founding Date 2002 | Founding Date 1998 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Houston, US HQ | Locations Boca Raton, US HQ | Locations San Diego, US HQ | Locations Vancouver, US HQ | Locations Bethesda, US HQ |
Employees | Employees 433% increase | Employees 22100% increase | Employees 980% increase | Employees 10 | Employees 1721% increase |
Valuation ($) | Valuation ($) 4.7 m | Valuation ($) 124.9 m | Valuation ($) 33.8 m | Valuation ($) 164.2 m | Valuation ($) 349.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $50k (FY, 2025) | Revenue (est.) $1m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $1.4m (FY, 2025) |
Net income | Net income ($15.9m) (FY, 2025) | Net income N/A | Net income ($13.4m) (FY, 2025) | Net income $3.7m (FY, 2025) | Net income ($60.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 23.2m | Total funding raised $ 115.7m | Total funding raised N/A | Total funding raised $ 135.9m |
For sources of this data, please see the company profile
View Company Profiles
INmune Bio
HQ
Boca Raton, US
Employees
22
INmune Bio is a clinical-stage biotechnology company that develops immunotherapies that reprogram a patient’s innate immune system.
View companyDare Bioscience
HQ
San Diego, US
Employees
9
Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
View companyCytodyn
HQ
Vancouver, US
Employees
10
CytoDyn is a biotechnology company developing therapies to address cancer, HIV, and other autoimmune diseases.
View companyNorthwest Biotherapeutics
HQ
Bethesda, US
Employees
17↑ 21% increase
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
View company